ITGA1 and neoplasm: Here, we applied the CD49a signature matrix to gene expression datasets of 225 hepatocellular carcinomas from GSE14520 as a training set, and 100 HCCs from TCGA-LIHC as validation cohort to evaluate a possible relation of CD49a + NK-cells within the tumor and the patient clinical outcome.